Last updated: February 1, 2024
Sponsor: Ain Shams University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Anxiety Disorders
Panic Disorders
Mood Disorders
Treatment
Melatonin 5 MG
Placebo
Clinical Study ID
NCT06237556
FMASU MD228/2023
Ages 40-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age from 40-60 years.
- Both sexes.
- Patients undergoing standard on-pump CABG with the same technique by the same surgicalteam.
Exclusion
Exclusion Criteria:
- Refusal of procedure or participation in the study by patients.
- Patients with known history of allergy to one of study drugs
- Patients taking psychiatric medications, CNS depressants, and hypnotic drugs.
- Patients with neurological disorders stroke, intracranial hemorrhage and surgery.
- Patients with a history of suffering from any sleep disorder.
- Severe circulatory or respiratory disease.
- Patients with obstructive sleep apnea.
- Cognitive or psychiatric illness that leads to inability to cooperate, speak orprovide informed consent
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Melatonin 5 MG
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
December 01, 2024
Study Description
Connect with a study center
Ain Shams University
Cairo, 11591
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.